Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.
The anti-CD19 chimeric antigen receptor (CAR) THP1 cell line is a stable cell line developed using anti-CD19 CAR lentivirus transfection. This transfected CAR lentiviral vector is constructed to express a scfv of anti-CD19 antibody (FMC63) linked to CD147 signaling domains.The anti-CD19 CAR engineered THP1 cells can be used to be differentiated into macrophage cells for in vitro or in vivo phagocytosis studies. This CAR-THP1 cell line product can be used for the researches of B cell lymphomas, acute lymphoblastic leukemia (ALL), and chronic lymphocytic leukemia (CLL).
Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.